Azaindole-derivatives as factor Xa inhibitors

Details for Australian Patent Application No. 2004238500 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Urmann, Matthias; Ritter, Kurt; Matter, Hans; Wehner, Volkmar; Will, David William; Nazare, Marc

Agent Watermark

Pub. Number AU-B-2004238500

PCT Pub. Number WO2004/101563

Priority 03011304.7 19.05.03 EP

Filing date 5 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 22 July 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/101563 Priority application(s): WO2004/101563

22 July 2010 Application Accepted

  Published as AU-B-2004238500

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238508-Imidazo-benzothiazoles

2004238499-Indazole-derivatives as factor Xa inhibitors